Exact Sciences报告早期癌症检测取得进展
威斯康星州麦迪逊 - 以癌症筛查和诊断测试而闻名的Exact Sciences Corp. (NASDAQ: EXAS)公布了研究结果，显示多癌症早期检测 (MCED)测试取得进展。在圣地亚哥举行的美国癌症研究协会特别会议上展示的研究表明，一种新的多生物标志物方法可以提高癌症检测率，尤其是在早期阶段。
Exact Sciences首席执行官Kevin Conroy购买价值100万美元的股票
威斯康星州麦迪逊市—Exact Sciences Corp (NASDAQ:EXAS)总裁兼首席执行官Kevin Conroy近期大量购入公司普通股。根据最新的SEC文件显示，Conroy于11月13日以每股51.35美元的价格购入19,500股，总投资额为1,001,325美元。 此次交易使Conroy的直接持股增加到1,074,191股。此外，他还通过退休和信托账户间接持有公司股票，以及683 ...
Yale Environment 3601 天
A basic science breakthrough: Evidence of a new type of superconductor
Yale physicist Eduardo H. da Silva Neto led an experiment that supports the existence of a new type of superconductor.
Biological sciences: Addressing global challenges while building a successful career
In 2015, the United Nations outlined 17 Sustainable Development Goals (SDGs) aimed at eradicating poverty, protecting our ...
bovnews2 天
Exact Sciences Corp (EXAS) Shock: Unpacking Today’s Price Drop
On Friday, Exact Sciences Corp (EXAS) stock saw a decline, ending the day at $51.48 which represents a decrease of $-1.75 or -3.29% from the prior close of $53.23. The stock opened at $53.14 and ...
11 New 4-Star Stocks
For the week ended Nov. 8, 11 stocks dropped into undervalued territory, meaning their Morningstar Ratings changed to 4 or 5 ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT), Pharvaris ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...
Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.
Exact Sciences may have had disappointing Q3 earnings, but its liquidity cushions and new product approval indicate strong ...